It may aid GLP-1 function somewhat, but effects are indirect and not comparable to GLP-1 receptor agonists
Diabetes 60 , 30673072 (2011)
In a statement, the company's CFO Ruby Kam said, "Costs for medical care and medications for our members have escalated rapidly and spending is now growing at the fastest rate in more than a decade
What kind of testing and standards apply to compounded medications
doi:.10.3233/NPM-1663 [PubMed: 28304323] [CrossRef] 193
However, precise analysis of the relationship between the cost of paying for GLP-1s and the return on investmentcost savings due to increased productivity and reduced health care utilizationmay become challenging as, in the United States, there are few mechanisms and incentives to produce these data and analyze them over the long term, Persad noted